Lilly Reports Strong First-Quarter 2018 Results, Raises EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Eli Lilly (LLY) PT Lowered to $78 at BMO Capital
April 25, 2018 7:13 AM EDTBMO Capital lowered its price target on Eli Lilly (NYSE: LLY) to $78.00 (from $79.00) while maintaining a Market Perform rating.
Analyst Alex Arfaei commented, "The revenue and EPS beat in 1Q18 looked impressive, but since it was driven by the mature... More
Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance
April 24, 2018 6:27 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.34, $0.21 better than the analyst estimate of $1.13. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.49 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2018 EPS of $5.10-$5.20, versus the... More
